Skip to main content

Suicidal Behavior

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Conception
ConceptionCA - Berkeley
1 program
Standardized assessment on depressed patientsN/A1 trial
Active Trials
NCT02904005Unknown2,000Est. Mar 2018
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Stepped Care for Suicide PreventionN/A1 trial
Active Trials
NCT03092271Completed301Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsStepped Care for Suicide Prevention
ConceptionStandardized assessment on depressed patients

Clinical Trials (2)

Total enrollment: 2,301 patients across 2 trials

NCT03092271Angeles TherapeuticsStepped Care for Suicide Prevention

Randomized Trial of Stepped Care for Suicide Prevention in Teens and Young Adults

Start: Apr 2017Est. completion: Mar 2022301 patients
N/ACompleted
NCT02904005ConceptionStandardized assessment on depressed patients

Predictors of Suicidal Behavior in Depression

Start: Mar 2015Est. completion: Mar 20182,000 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.